CHARACTERIZING IMMUNOLOGICAL AND GENOMIC RESISTANCE MECHANISMS TO ANTI-PD-1 IMMUNOTHERAPY IN SMOKING-ASSOCIATED HEAD AND NECK CANCER
$655,000FY2022Defense Health AgencyDOD
The Feinstein Institutes For Medical Research
The Feinstein Institutes For Medical Research